GEODE CAPITAL MANAGEMENT, LLC
Position in PTGX — Protagonist Therapeutics, Inc
CIK 1214717
BOSTON, MA
Position in PTGX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$213,437,399
+$37,485,696 QoQ
Shares Held
1,741,209
+4.3% QoQ
Ownership
2.69%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#13
of 341 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,426,307 across 521 Biotechnology names. PTGX ranks #23 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in PTGX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $213,437,399 | 1,741,209 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $175,951,703 | 1,669,371 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $126,898,731 | 1,452,928 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $94,107,793 | 1,416,646 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $79,822,591 | 1,444,230 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $68,843,313 | 1,423,559 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $53,154,631 | 1,377,063 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $61,861,365 | 1,374,697 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $47,511,005 | 1,371,169 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $37,427,869 | 1,293,739 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $28,623,152 | 1,248,284 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $19,703,350 | 1,181,256 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $29,751,822 | 1,077,184 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $21,297,839 | 925,993 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $9,599,610 | 879,891 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $6,975,454 | 827,456 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $6,501,395 | 821,921 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $19,723,569 | 832,921 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $26,610,370 | 778,081 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $12,916,639 | 728,930 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $32,037,049 | 713,838 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $16,723,086 | 645,679 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $10,247,348 | 508,301 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $8,584,678 | 439,114 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $6,505,414 | 368,370 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $2,072,787 | 293,596 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||